Product Information
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by American Regent, Inc., priced at $2.1633 per ML under NDC 00517760425. Its NADAC has been published 279 times since May 20, 2020.
FDA first approved this application on Jul 28, 1995. Its Orange Book therapeutic-equivalence code is AN.
Strength
200 mg/mL
Manufacturer
American Regent, Inc.NDC
00517760425
Classification
Generic
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA072547FDA Approved
7/28/1995
TE Code
AN
On Market Since
10/1/1995
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 279 times since May 20, 2020, and over the history we have for it it has risen 10.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1633 per ML |
|---|---|
| All-time high | $2.6444 (Oct 15, 2025) |
| All-time low | $1.6443 (Sep 23, 2020) |
| 52-week high | $2.6444 |
| 52-week low | $2.1633 |
| Median price | $2.1234 |
| Average price | $2.0770 |
| Largest weekly change | +32.7% (Aug 23, 2023) |
| Weeks tracked | 279 |
| Tracking since | May 20, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by American Regent, Inc., is $2.1633 per ML (NDC 00517760425), effective Aug 19, 2026.
How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 10.6%. It has been tracked across 279 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Since May 20, 2020, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $1.6443 (Sep 23, 2020) to a high of $2.6444 (Oct 15, 2025), with a median of $2.1234 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETYLCYSTEINE 20% VIAL, is $1.1883 per ML — about 45% below ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION).
Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 00517760425) is labeled by American Regent, Inc., and CMS classifies it as a generic product.